// App-Quantinova.ai

TCT-188 : Two-Year Clinical Outcome of Patients With Bifurcation Lesions Treated With Second-generation Zotarolimus-Eluting Resolute Stents and Everolimus-Eluting Xience V Stents in the Randomized TWENTE Trial

Researchers

Presenter

  • Kenneth Tandjung

Principal Investigators

  • Hanim Sen

  • Ming Kai Lam

  • Marije M. Lowik

  • Gert van Houwelingen

  • Martin G. Stoel

  • Hans W. Louwerenburg

  • F. De Man

  • Gerard C. Linssen

  • Rogier Nijhuis

  • Mark B. Nienhuis

Medical Centers

  • Ziekenhuisgroep Twente (ZGT), Almelo, Netherlands

  • Arthritis Centre Twente, Medisch Spectrum Twente, Enschede, Netherlands

  • Thoraxcentrum Twente & University of Twente, Enschede, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • ZoMaxx

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved